Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Zoetis (NYSE:ZTS) Stock: Can the Animal-Health Leader Re-Earn Its Premium After a Guidance Cut?

Few names in animal health carry the heft of Zoetis, Inc (NYSE:ZTS), and after a bruising stretch for the shares the September 2026 setup has become a genuine test of the market-leader thesis. The world's largest pure-play animal-health company now trades near $73, a …

Vinay Lochav | 10 September 2026

What's Next for ZyVersa Therapeutics, Inc (OTC:ZVSA)? Its Stock Waits for the Next Big Signal

● The tiny daily move in ZVSA shares reflects the mechanics of a sub-penny-adjacent, thinly traded micro-cap rather than any confirmed news event; such stocks routinely swing on minimalVolumewithout an identifiable catalyst.

Vinay Lochav | 10 September 2026

Zhengye Biotechnology (NASDAQ:ZYBT) Stock: Key Levels and Catalysts to Watch

China's livestock-vaccine sector rarely surfaces on U.S. exchanges, which makes Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) a distinctive small-cap.

Vinay Lochav | 10 September 2026

VivoSim Labs, Inc (NASDAQ:VIVS) Shares Slip: What's Pressuring It and What Comes Next?

● The small share decline has no single, clearly identifiable public catalyst, and for a sub-dollar stock, ordinaryVolatilityand the overhang from recentCapitalraises are plausible background factors.

Vinay Lochav | 10 September 2026

This OTC:VNTH Mobile-Health Stock Jumped 50% on Thin Air

A stock priced in hundredths of a cent rarely commands headlines, yet Nano Mobile Healthcare, Inc (OTC:VNTH) drew a burst of speculative interest after a sharp single-session percentage swing. At these prices, even a fractional move translates into an eye-catching percentage, and the company …

Vinay Lochav | 10 September 2026

ViewRay's (OTC:VRAYQ) MRI-Guided Radiation Technology Couldn't Save It From Chapter 11

ViewRay, Inc (OTC:VRAYQ) built its reputation on a genuinely differentiated technology: MRIdian, a system that combines magnetic-resonance imaging with radiation therapy to target tumors in real time. Yet a compelling product did not translate into a durable business, and the company's stock now lingers …

Vinay Lochav | 10 September 2026

Vistagen Therapeutics (NASDAQ:VTGN) Stock: What's Pressuring the Clinical-Stage Biopharma

Vistagen Therapeutics (NASDAQ:VTGN)' shares have drifted into penny-stock territory, and the recent weakness follows a pivotal setback for the company's lead anxiety program. The San Carlos, California biopharma built much of its narrative around fasedienol, an investigational intranasal "pherine," and a late-stage clinical miss …

Vinay Lochav | 10 September 2026

Vivos Therapeutics (NASDAQ:VVOS) Stock: What Could Turn the Sleep-Device Maker Around

A sleep-medicine company posting double-digit revenue growth would normally command a healthier share price than Vivos Therapeutics, Inc (NASDAQ:VVOS) currently does. Trading below $0.20 in September 2026, the Colorado-based maker of oral appliances for obstructive sleep apnea and related airway disorders is delivering its …

Vinay Lochav | 10 September 2026

VirExit Technologies Inc (OTC:VXIT) Stock Pops: Could It Be Setting Up for Another Move?

● At a quoted price near $0.0004, that move reflects the arithmetic of extremely low-priced stocks, where the smallest price increment can equal a large percentage of the share price; it is not tied to any confirmed public catalyst.

Vinay Lochav | 10 September 2026

Vycor Medical (OTC:VYCO) Stock: A Quiet Quote Hiding Modest, Real Revenue Growth

Vycor Medical, Inc. (OTC:VYCO) is one of those small medical-device companies that rarely generates headlines, and the ticker VYCO has been living up to that reputation in September 2026. Trading over the counter at pennies per share, the Boca Raton, Florida company sits well …

Vinay Lochav | 10 September 2026
Support

Hi! How can we help you today?

Loading…